PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Suanzaoren led to significant subjective sleep quality improvements in participants with insomnia compared to placebo [PMID:37014010]. Meta-analysis of 12 RCTs showed Suanzaoren decoction (SZRD) was superior to control groups in improving clinical effective rates [PMID:36459033].
Jiawei Suanzaoren decoction demonstrated therapeutic effects in people with yin deficiency and fire excess type insomnia [PMID:39944400].
Modified Suanzaoren decoction (MSZRD) treatment resulted in increased functional activity in the left middle frontal gyrus compared to baseline [PMID:40384005].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 34509822 (2021) — Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- 2.PMID: 38160863 (2024) — SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1/Nrf2 signaling pathway. · Journal of ethnopharmacology
- 3.PMID: 36720435 (2023) — Research progress of quality control for the seed of Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F. Chow (Suan-Zao-Ren) and its proprietary Chinese medicines. · Journal of ethnopharmacology
- 4.PMID: 40826721 (2025) — Chinese herbal medicine for insomnia: A systematic review and network meta-analysis. · Medicine
- 5.PMID: 37156059